FierceBiotechOriginal article
{"a":[{"_":"Roche ends 2 Huntington’s disease programs, including Ionis-partnered tominersen","$":{"href":"/biotech/roche-ends-2-huntingtons-disease-programs-including-ionis-partnered-tominersen","hreflang":"en"}}]}
rejectedtominersenNegative
AI Analysis
Summary
Roche has halted development of two Huntington's disease programs, including tominersen developed in partnership with Ionis, representing a significant setback for the patient community awaiting new treatments.
Outcome Details
Roche halted development on two Huntington's disease programs, including the Ionis-partnered tominersen
Importance:6/10
Sentiment:
-0.80
program terminationHuntington's diseasepartnership impactdrug development
Read the original article
Published by FierceBiotech on July 9, 2026 2:09 PM